Functional Endoscopic Evaluation of Swallowing

Cerebral Palsy Clinical Trial

Official title:

Achados da avaliação videoendoscópica da deglutição em crianças Com Paralisia Cerebral.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00717028
• Other study ID #: 198/2005
• Status: Completed
• Phase: N/A
• First received: July 14, 2008
• Last updated: July 14, 2008
• Start date: September 2005
• Est. completion date: November 2005

Study information

• Verified date: September 2005
• Source: Fortaleza University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: National Committee of Ethics in Research
• Study type: Observational

Clinical Trial Summary

The investigators objective is to describe functional endoscopic evaluation of swallowing findings in children with cerebral palsy.

Description:

Cerebral palsy (CP) is a predominantly motor disorder and dysphagia is a frequent complaint. Functional endoscopic evaluation of swallowing (FESS) involves anatomic and functional observation of the larynx and pharynx, evaluation of swallowing and maneuvers to improve it, also testing the laryngeal sensitivity. We evaluated nine patients with CP of both sexes, which age varied from 1 to 10 years old, attended at dysphagia multidisciplinary clinic, at NAMI (Integrated Medical Assistance Nucleons).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 9
• Est. completion date: November 2005
• Est. primary completion date: November 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Year to 10 Years

Eligibility

Inclusion Criteria:

• medical diagnosis of cerebral palsy.

Exclusion Criteria:

• medical diagnoses not associated with cerebral palsy that affect swallowing.

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Cerebral Palsy
• Dysphagia

Locations

Country	Name	City	State
Brazil	Dysphagia multidisciplinary clinic at Integrated Medical Assistance Nucleons	Fortaleza	Ceará

Sponsors (1)

Lead Sponsor	Collaborator
Fortaleza University

Country where clinical trial is conducted

Brazil,